Peter Clausi on how CBLT has used creative M&As in gold and battery metals to make money for their shareholders

In a recent InvestorIntel interview, Tracy Weslosky asks Peter Clausi, President, CEO and Director of CBLT Inc. (TSXV: CBLT) to explain what he meant by his line that “a mining company can make more money with a pen than with a drill bit.” He responds on how this works with market cycles and then adds that as a result of their focus on strategic M&A activities that “CBLT has not had to do financing since 2016.” He then goes on to explain how CBLT has found creative M&As to make money for their shareholders.

In this InvestorIntel interview, which may also be viewed on YouTube (click here to subscribe to the InvestorIntel Channel), Peter went on to say, “Two years ago, CBLT bought a portfolio of assets for little over $1 million in stock. Northshore gold was one of the assets in the portfolio which was sold for $1.45 million.” He also provided an update on the Big Duck Lake gold property on which Peter said “…is analogous to the Moose Lake Porphyry which hosts the Hemlo Gold Camp.” Commenting on the cobalt market Peter said, “If you believe that we are going to greenify the world, if you believe that there is a run on Lithium — then you have to believe that there is a run on cobalt.”

To watch the full interview, click here

About CBLT Inc.

CBLT Inc. is a Canadian mineral exploration company with a proven leadership team, targeting cobalt and gold in reliable mining jurisdictions. CBLT is well-poised to deliver real value to its shareholders.

To learn more about CBLT Inc., click here

Disclaimer: CBLT Inc. is an advertorial member of InvestorIntel Corp.




Michael Lende on a Health Canada approved touchless fever detection system that can help identify potential at-risk carriers

Peter Clausi with Predictiv AI CEO Michael Lende on the touchless ThermalPass Fever Detection System

In a recent InvestorIntel interview Peter Clausi speaks with Michael Lende, President and CEO of Predictiv AI Inc. (TSXV: PAI), about their ThermalPass Fever Detection System. Michael said that ThermalPass is a Health Canada approved touchless fever detection system that can help identify potential at-risk carriers.

In this InvestorIntel interview, which may also be viewed on YouTube (click here to subscribe to the InvestorIntel Channel), Michael went on to say that camera-based sensors have privacy issues but Predictiv AI’s ThermalPass Fever Detection System uses thermal medical grade sensors which are nonintrusive and preserves anonymity of the people passing through. “It can scan 60 people per minute.” He added. “There are 24 medical grade sensors in the ThermalPass, each taking 100 readings per second. It is quite accurate as you are going through.” To watch the full interview, click here

About Predictiv AI:

Predictiv AI Inc. is a technology company which helps businesses and organizations make smarter decisions using advanced artificial intelligence, deep machine learning and data science techniques. Its Weather Telematics Inc. subsidiary uses patented air quality monitoring sensors to provide predictive weather risk information to the insurance, logistics, fleet management and public safety sectors. The Company’s R&D division, AI Labs Inc., develops new products that solve real-world business problems. The joint venture with Commersive Solutions Corp. is developing innovative technologies for use in various public spaces, starting with the ThermalPass™ fever detection system. To learn more about Predictiv AI Inc., click here

Disclaimer: Predictiv AI Inc. is an advertorial member of InvestorIntel Corp.




MedX Health explains why no one should ever die from skin cancer

InvestorIntel’s Tracy Weslosky talks with MedX Health Corp.‘s (TSXV: MDX) Executive Chairman & CEO Robert Von Der Porten and Mike Druhan, President of Dermatology Services.

“Nobody should ever die from skin cancer,” said Robert. “Unfortunately people still do, and we have technology to solve that problem.”

“MedX is in the teledermatology space, so we are sort of a specialized version of telemedicine,” Mike said in the interview. “Our ability to go 2mm below the skin and catch a spectrophotometric view of the disorganization under the skin is our hallmark differentiation. Other competing technologies have about 40% rejection rate on the image quality. Our technology does not have a rejection rate because every image is absolutely perfect.”

Pointing to their dermatologist-designed questionnaires that form a part of MedX’s telemedicine platform, Robert said the advantage is that “dermatologists can very quickly, and time-effectively assess a patient’s condition, the surrounding area condition and if it is a mole or lesion, which is potentially cancerous. It is a very powerful platform that can be deployed anywhere.”

To access the complete interview, click here

Disclaimer: MedX Health Corp. is an advertorial member of InvestorIntel Corp.




James Howard-Tripp on applying StageZero’s cancer diagnostics expertise to COVID-19 testing

InvestorIntel’s Tracy Weslosky talks with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences Ltd. (TSX: SZLS), about StageZero’s early detection of cancer diagnostics and its new testing technology for COVID-19. Tracy observed, “You have one of the highest volume stock. You recently had a buy recommendation from Clarus Securities. What do you attribute all this recent attention to?” she asked.

“Fifteen years of work,” James replied.

“We are a cancer diagnostic company. So, when you deal with cancer everything needs to be absolutely precise,” James added. “When you move into another line, which is testing for COVID-19, you have to bring the exact same rigor to it. Everything that we do is to ensure that it is as precise as possible.” StageZero’s Aristotle testing platform can identify ten different types of cancer from a single blood test. “We believe that it will be in the market by year end. We are now completing the last of the validation,” James said.

To watch the complete interview, click here

Disclaimer: StageZero Life Sciences Ltd. is an advertorial member of InvestorIntel Corp.




David Morgan on why the gold and silver ride is not over yet

InvestorIntel’s Tracy Weslosky asks David Morgan, Founder & Owner of The Morgan Report, if it is too late to invest in the gold and silver market. “From my work and many others we are in the last leg of this major move.” David said. “The greatest price appreciation takes place in the last leg, but the last leg is usually short in duration. 90% of the move comes in the last 10% of the time.”

“We are in a monetary conundrum,” David told Tracy. “We are printing our way out of a mess that can’t be printed out of. So, the metals are going to react to that in a very significant way, probably in a very short duration. Juniors are the last to participate in any cycle,” David added. “I think there is so much pressure in the precious metals right now, juniors may participate a little earlier than they normally do.”

Last month InvestorIntel announced its partnership with InvestorChannel.com, a data-driven fintech company that is focused on using the latest in artificial intelligence (AI) and other analytics technologies to develop a platform that produces timely insights into companies and industries listed on the capital markets. InvestorChannel publishes a daily Silver Stocks Watchlist Update video which includes the Top 5 Performers of the Day and a performance review of the companies InvestorChannel is following in the sector, carefully selected by silver expert David Morgan of The Morgan Report.

To watch the complete interview, click here




Euro Sun Mining’s Rovina Valley Gold Project getting the attention it deserves

InvestorIntel’s Peter Clausi talks with Scott Moore, President and CEO of Euro Sun Mining Inc. (TSX: ESM)  about Euro Sun’s Rovina Valley Gold Project. “We are probably one of the cleanest projects out there. We don’t use cyanide. We don’t use wet tailings,” Scott said. “Porphyry projects usually have big CapEx. We don’t have a big CapEx,” he added, owing to cheap power, skilled labour force and great infrastructure. “It is big. We can move earth inexpensively and we can make a lot of money particularly with the simple processing that we have.”

Scott also provided an update on Euro Sun’s recently closed C$22.3 million bought deal financing. “We had $17 million of institutional demand in the financing,” he said. “The institutional demand was international, from United States, Hong Kong, Paris, and London with three of the largest funds that are out there – Ruffer, Franklin Templeton and ASA Gold taking significant positions.” Commenting on what’s coming up for Euro Sun, Scott noted that “the stock has gone from 15 cents in March to 60 cents now,” with “some significant catalysts coming up in the next 6 to 12 months.”

To watch the complete interview, click here

Disclaimer: Euro Sun Mining Inc. is an advertorial member of InvestorIntel Corp.




The Rare Earths War

Technology Metals Show host Tracy Weslosky moderates a timely discussion on how China poses a serious threat to the rare earths supply chain security of the United States, talking to international rare earths expert Jack Lifton and the Editor of “The Rare Metals War” Guillaume Pitron. Guillaume observed that Donald Trump as the President has been tackling the rare earths supply chain issue like no one ever done in this role. He added, “If he is re-elected, I believe, that is going to impact in a good way the US production of rare earth minerals and rare earth metals.”

Jack agreed with Guillaume and added, “Trump is the first president to refocus on globalization, and he is trying to de-globalize critical materials for the security of the United States.” Highlighting the seriousness of the rare earths supply chain problem, Jack said that Shin-Etsu and Hitachi, two large Japanese companies that supply rare earth magnets to the US military, have most of their production in China.

Jack also revealed that China recently announced that they would cut off Northrop Grumman, an American defense technology company, from all Chinese rare earth materials. “What Americans don’t seem to be paying attention to,” Jack continued, “is Grumman is the producer of the F-35 fighter plane, the greatest air superiority weapon in history. Grumman needs those rare earths to build those planes. This is going to bring real pressure on the defense department.”

To access the complete interview subscribe to the Technology Metals Show and get exclusive access to members-only content through this exclusive site. Or Log-In Here for the latest conversations, debates, updates and interviews with the leaders, thought leaders and investors focused on issues relating to sustainability in the critical materials sector.

For more information on the Technology Metals Show email us at info@technologymetals.com or reach us direct at +1 (416) 546-9233